SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): March 2, 2004
Arrhythmia Research
Technology, Inc.
(Exact name of
issuer as specified in its charter)
| Delaware | 1-9731 | 72-0925679 |
| (State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer Identification Number) |
| Incorporation or organization) |
25 Sawyer Passway
Fitchburg, MA 01420
(Address of principal
executive offices and zip code)
(978) 345-5000
(Registrant’s telephone number, including area code)
| Item
5. Other Events and Regulation FD Disclosures | |
| On March 2, 2004 Arrhythmia Research Technology, Inc. (the “Company”) announced that its wholly owned subsidiary, Micron Products, Inc., has entered into a non-binding letter of intent to purchase substantially all of the operating assets of New England Molders, Inc. The Company issued a press release dated March 2, 2004, which is attached as Exhibit 99.1 to this report. |
| Item
7. Financial Statements, Pro Forma Financial Information and Exhibits | |
| (c). Exhibits |
| Exhibit Number | Description | |
|---|---|---|
| 99.1 | Press Release dated March 2, 2004 announcing proposed asset purchase. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Fitchburg, Commonwealth of Massachusetts, on the
3rd day of March 2004.
| ARRHYTHMIA RESEARCH TECHNOLOGY, INC. | |
| By: /s/ David A. Garrison | |
| David A. Garrison | |
| Chief Financial Officer |
| Exhibit Number | Description | |
|---|---|---|
| 99.1 | Press Release dated March 2, 2004 announcing proposed asset purchase. |